Physician profile
Jonathan K Bakos
NPI 1609361278
$2,330.51
in general payments reported to CMS, 2019-2025
35 companies · $962 in 2025
The $962 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $72.24 · 2024: $1,296 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,132 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,131.52 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $251.74 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Janssen Biotech, INC. | $246.72 | 2024-2025 | Tecvayli, Darzalex, Rybrevant |
| Celgene Corporation | $194.14 | 2024-2025 | Reblozyl |
| Novocure INC. | $185.11 | 2024-2025 | Optune Lua (Novottf-200t) |
| Sobi, INC | $167.56 | 2024-2025 | |
| Incyte Corporation | $132.23 | 2024 | Pemazyre, Monjuvi, Jakafi |
| E.R. Squibb & Sons, L.L.C. | $108.03 | 2024-2025 | Opdivo, Krazati |
| Regeneron Healthcare Solutions, INC. | $100.82 | 2024-2025 | Libtayo |
| Novartis Pharmaceuticals Corporation | $74.89 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $72.24 | 2023 | Talvey, Tecvayli, Darzalex |
| Pfizer INC. | $68.88 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.79 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.36 | 2024 | Alunbrig |
| Array Biopharma INC | $49.16 | 2024-2025 | Lorbrena, Braftovi |
| Geron Corporation | $45.11 | 2025 | Rytelo |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adc Therapeutics America, INC. | $44.51 | 2025 | |
| Taiho Oncology, INC. | $44.50 | 2024 | |
| Genzyme Corporation | $37.40 | 2025 | |
| Astellas Pharma US INC | $33.38 | 2025 | Xtandi |
| Aveo Pharmaceuticals, INC. | $31.71 | 2024 | |
| Lilly USA, LLC | $29.74 | 2024 | Jaypirca, Verzenio |
| Pharmacosmos Therapeutics INC. | $29.21 | 2025 | Monoferric |
| Blueprint Medicines Corporation | $29.17 | 2024 | Ayvakit |
| Bayer Healthcare Pharmaceuticals INC. | $25.66 | 2025 | |
| Eisai INC. | $24.29 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $24.18 | 2025 | Imfinzi |
| Daiichi Sankyo INC. | $23.68 | 2024 | Enhertu |
| Kite Pharma, INC. | $22.02 | 2025 | Yescarta |
| Jazz Pharmaceuticals INC. | $21.99 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $21.28 | 2025 | Onivyde |
| Genentech USA, INC. | $20.69 | 2024 | Phesgo |
| Glaxosmithkline, LLC. | $19.33 | 2024 | Ojjaara |
| Stemline Therapeutics INC. | $18.66 | 2025 | Elzonris |
| Servier Pharmaceuticals LLC | $16.60 | 2024 | |
| Tempus Ai, INC | $14.73 | 2025 | Xt Cdx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bakos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.